NCT07081841Enrolling by invitation
AB-1005 Long-Term Follow-up Study
Long-Term Safety and Efficacy Follow-up of AB-1005 Gene Transfer Study Participants With Parkinson's Disease or Multiple System Atrophy
Source: ClinicalTrials.gov · Last updated 2 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 132 (estimated)
- First submitted
- 9 Jun 2025
- Start date
- 4 Sept 2025
- Primary completion date
- 30 Sept 2037
- Lead sponsor
- AskBio Inc
- Diseases
- Parkinson disease
- NCT number
- NCT07081841
What you commit to
- Study type: Observational
- Planned participants: 132
- From 4 Sept 2025 to the primary completion date, 30 Sept 2037
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- There are no exclusion criteria
Who the study is looking for
- PD and MSA-P participants that are or were enrolled in an interventional AB-1005 study and provide informed consent
Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ohio State University Coordinator of this site? Confirm its status | Columbus | United States | Unknown status |
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.